A topical cream that helps regulate macrophage activity was effective in treating diabetic foot ulcers, a clinical trial reported. In 236 patients with foot ulcers treated for 16 weeks, the proportion ...

Living with diabetes means constantly keeping an eye on things that most people never have to think twice about. Blood sugar levels, skin changes, foot checks, and meal planning become a way of life.

Mr. J’s medical history included type 2 DM, DFU with osteomyelitis, obesity, hypothyroidism, and hyperlipidemia. Medications included insulin (Humulin 70/30) b.i.d., levothyroxine, pravastatin, ...

Diabetic patients, especially those with very high hyperglycemia, are at an increased risk of developing foot sores or ulcers. 1 The ulcers are often painless, which may be due to neuropathy or nerve ...

The development of new treatments for diabetic foot ulcers has stalled for the past 2 decades, and novel, effective methods of tackling this debilitating condition are greatly needed, according to a ...

Standard wound care for diabetic foot ulcers involves vascular assessment, surgical debridement, use of appropriate dressings, infection management, and glycemic control; however, standard care is ...

BALERNA, Switzerland--(BUSINESS WIRE)--Results of a clinical study recently published in the scientific journal “The International journal of Lower Extremity Wound” show Nexodyn® AcidOxidizing ...

A simple stress ball has been shown to significantly reduce anxiety and pain during sharp debridement commonly used in nursing homes to promote wound healing. Previous research found that squeezing a ...

A comprehensive foot examination is essential for the appropriate assessment, prevention and management of diabetic foot complications Peripheral neuropathy is concurrent with 90% of foot ulcers and ...

The diabetic foot ulcer that cost Otis Dahmer one of his little toes began with what appeared to be nothing more than dry, flaking skin. Not being “much of a moisturizer guy,” Dahmer said, he didn’t ...

The first patient has been dosed in a Phase III trial assessing ViroMed’s VM202, the first pivotal study of a gene therapy indicated for patients with nonhealing diabetic foot ulcers (NHU) and ...